SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-000541
Filing Date
2017-03-13
Accepted
2017-03-13 08:02:45
Documents
13
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-013117.htm 10-Q 382076
2 EXECUTIVE COMPENSATION AGREEMENT - KENNETH L. WAGGONER pharmacyte_10q-ex1001.htm EX-10.1 52385
3 EXECUTIVE COMPENSATION AGREEMENT - CARLOS A. TRUJILLO pharmacyte_10q-ex1002.htm EX-10.2 54928
4 EXECUTIVE COMPENSATION AGREEMENT - GERALD W. CRABTREE pharmacyte_10q-ex1003.htm EX-10.3 52223
5 FOURTH STOCK OPTION AGREEMENT - GERALD W. CRABTREE pharmacyte_10q-ex1004.htm EX-10.4 32981
6 THIRD STOCK OPTION AGREEMENT - CARLOS A. TRUJILLO pharmacyte_10q-ex1005.htm EX-10.5 32891
7 FOURTH STOCK OPTION AGREEMENT - KENNETH L. WAGGONER pharmacyte_10q-ex1006.htm EX-10.6 32785
8 AMENDMENT #1 TO DIRECTOR OFFER LETTER pharmacyte_10q-ex1007.htm EX-10.7 12373
9 CERTIFICATION pharmacyte_10q-ex3101.htm EX-31.1 7690
10 CERTIFICATION pharmacyte_10q-ex3102.htm EX-31.2 7695
11 CERTIFICATION pharmacyte_10q-ex3201.htm EX-32.1 3968
12 CERTIFICATION pharmacyte_10q-ex3202.htm EX-32.2 3969
13 GRAPHIC pharmacyte_logo.jpg GRAPHIC 10119
  Complete submission text file 0001683168-17-000541.txt   691269
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 17683975
SIC: 2833 Medicinal Chemicals & Botanical Products